Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx

Abstract

Current management of T3N0M0 glottic laryngeal cancer relies largely on RT-based organ preservation approaches. The present study substantiates randomized clinical trial data supporting the use of RT-based organ preservation approaches for patients with T3N0M0 glottic laryngeal cancer without compromising OS.